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Certain strains of Staphylococcus epidermidis resistant to the aminoglycoside anti-
biotics were shown to contain an enzyme that inactivates the kanamycins, neo-
mycins, butirosins, paromomycin, gentamicin A, amikacin, and tobramycin by
adenylylation. Tobramycin adenylyltransferase, as this enzyme is called, was
found to be optimally active at pH 5.5. With paromomycin or neomycin Band C
as substrates, however, two pH values (5.5 and 9.0) for optimal activity were
observed. The enzyme requires Mg+ + for activity and is stabilized significantly
by dithiothreitol. It is probable that the 4'-hydroxyl group of ring I of the anti-
biotics is adenylylated. Those aminoglycosides that are not substrates for the
enzyme lack a hydroxyl group in the corresponding position.
An epidemiological study of the frequency of
resistance of staphylococci to aminoglycosides
showed that 2% of isolates of Staphylococcus
epidermidis were inhibited by ~ 12.5 ug of to-
bramycirr/rnl. Such tobramycin-resistant (TmR )
strains were also resistant to kanamycin A, paro-
momycin, butirosin, and gentamycin A and inter-
mediately resistant to neomycin and amikacin.
In a genetic study of Tm R in such strains, it was
found that resistance was conferred by a small
plasmid (mol wt, 2.7 X 106 daltons) present in
multiple copies [1]. Loss of this plasmid resulted
in tobramycin-susceptible variants, which were
also susceptible to the other aminoglycosides ex-
cept streptomycin.
We now report that the mechanism of resis-
tance to aminoglycosides in these staphylococci
can be explained by the production of an adenyl-
ylating enzyme. We propose to call this enzyme
by the trivial name tobramycin adenylyltransfer-
ase, because it was detected in staphylococci
unusually resistant to tobramycin, and tobramycin
was found to be one of the best substrates for it.
Materials and Methods
Antibiotics and chemicals. Tobramycin was
supplied by Eli Lilly and Company (India-
Please address requests for reprints to Dr. F. H.
Kayser, Institute of Medical Microbiology, 8028 Zurich,
Switzerland.
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napolis, Ind.) ; the kanamycins A, B, and C,
amikacin (BB-K8), and butirosin by Bristol
Laboratories (Syracuse, N.Y.); neomycins Band
C and spectinomycin by the Upjohn Co. (Kala-
mazoo, Mich.); paromomycin by Parke, Davis
and Co. (Detroit, Mich.); and the gentamicins
C ll C:!, C1ll , and A and sisomicin by Schering
Corp. (Bloomfield, N.J.). The other antimicro-
bial agents were provided by the pharmacy of
the University Hospital (Zurich, Switzerland).
Radiolabeled chemicals were bought from the
Radiochemical Centre (Amersham, England) .
Dithiothreitol and adenosine triphosphate (ATP)
were obtained from Calbiochem (Los Angeles,
Calif. ). All other inorganic salts of analytic grade
were obtained from Merck (Darmstadt, Federal
Republic of Germany).
Organism. The representative strain used for
our studies was S. epidermidis strain 109, which
was isolated from clinical material obtained in
Zurich. In addition to tobramycin, this strain is
resistant to penicillin (Pen"), chloramphenicol
(CmR ) , tetracycline (TcR ) , streptomycin (SmR ) ,
and sulfamethoxazole (SMZH) and is moderately
resistant to methicillin (Meth"). The organism
was maintained on brain-heart infusion agar
(Difco, Detroit, Mich.) containing 20 ug of neomy-
cirr/rnl. For production of enzyme, the strain was
subcultured on brain-heart infusion agar contain-
ing 10 ug of neomycin Byrnl. The culture was
inoculated into 2 ml of a medium composed of
Bacto-tryptone (Difco), 109; Bacto-yeast extract
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(Difco), 50 g; NaCl, 10 g; glucose, 4 g; and an
amount of water sufficient to make 1 liter. The
pH was adjusted to 7.2. For growth of the in-
oculum, this medium contained 10 ug of neomy-
cin B/ml. After overnight incubation, 1 ml of the
inoculum was inoculated into 100 ml of fresh
medium, which was incubated in a shaking water
bath at 37 C. At the beginning of the exponential
phase of growth, 1 ml of neomycin B (400 /lg/
ml) was added to the culture. When the culture
reached an OD of about 1 at 550 nm, cells were
harvested by centrifugation at 11,000 g for 10 min
at 4 C and were washed twice with 40 ml of a
cold buffer containing 0.01 M Tris and 0.03 M
NaCI (pH 7.8).
Production of enzyme. The osmotic shock
method [2], slightly modified, was used. The
washed cells were suspended in 10 ml of 0.033 M
Tris-HCl buffer (pH 7.3) containing 0.003 M
EDTA and 20% sucrose. After it stood at room
temperature (about 20 C) for 30 min, the sus-
pension was stirred with a magnetic stirrer for
5 min and centrifuged for 15 min at 12,000 g and
4 C. The supernatant was discarded, and the re-
maining sucrose was removed carefully from the
wall of the centrifuge tubes with cotton swabs.
The pellet of cells was suspended in 5 ml of an
ice-cold solution of 0.0005 M MgCI2, and the
suspension was aspirated forcefully about 20
times with a 5-ml pipette. After stirring for 5 min
and centrifugation for 15 min (22,000 g) at 4 C,
the supernatant was carefully decanted to a flask
containing 150 III of a 0.04 M solution of
dithiothreitol.
For preparation of extracts by sonification, the
washed cells were "Suspended in an ice-cold solu-
tion of 0.0005 M MgCI2, frozen at - 70 C,
thawed rapidly, and sonified for 3 min at 55 W
(Branson sonifier B-12; Branson, Danbury,
Conn. ). The procedure was repeated once, after
which the suspension was centrifuged for 15 min
at 22,000 gat 4 C. The supernatant was decanted
and stabilized with dithiothreitol.
For preparation of lysates, cells were lysed by
lysostaphin according to procedures described by
Shaw and Brodsky [3].
Enzymatic assay. The methods used were
similar to those described by Benveniste et al.
[4] and to those by Davies et al. [5]. The assay
for adenylylation consisted of 20 III of cell extract
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(0.5-1.0 mg of protcin/rnl), 1.5 umol of buffer,
0.5-0.7 umol of MgCb, 55 nmol of dithiothreitol,
20 nmol of [2-3H]ATP (specific activity, 60
IlCi/llmol), and 0.6-0.8 nmol of drug base (total
volume, 65 Ill). After incubation at 35 C for
various periods, 50-Ill samples were pipetted onto
a 2-cm 2 phosphocellulose paper (Whatman P-81;
Balsbon, Maidstone, England), which was washed
twice with double-distilled water and dried at 55 C.
Radioactivity was counted in a Packard Tri-Carb
scintillation spectrometer (Packard Instruments,
Downers Grove, Ill.) in 10 ml of· a toluene-based
scintillation fluid. Reaction mixtures devoid of
either the enzyme or the drug were used as con-
trols for nonspecific binding of [2-3H]ATP. When
adenylylation had to be measured before com-
pletion of the reaction, the tubes containing the
reaction mixtures were chilled in ice-water for
termination of the reaction. The amount of drug
used in all experiments was within the linear
range of a quantitative assay.
Acetylating and phosphorylating activities in
the cell extract were checked according to
methods described by Haas and Davies [6] and
Benveniste and Davies [7].
Assays for inactivation of drugs. After com-
pletion of the reaction, 50 III of the reaction
mixture containing the ingredients mentioned
above were placed in wells punched in antibiotic
agar no. 3 (Difco) containing 104 spores of
Bacillus subtilis (ATCC 6633)/ml as the test
organism, and inactivation of drugs was checked.
After incubation at 30 C for 24 hr, the degree of
inactivation was measured by comparison of the
zones of inhibition with appropriate controls.
MIC of drugs. The MIC of antibiotics was
determined in Mueller-Hinton broth (Baltimore
Biological Laboratories, Baltimore, Md.) [8].
Protein assay. The protein content of cell
extracts was measured by the method of Lowry
et al. [9].
Results
Enzymatic inactivation of aminoglycosides.
Natural resistance to aminoglycosides in gram-
positive and gram-negative bacteria is usually the
result of a chemical modification and the con-
sequent inactivation of the antibiotics by certain
enzymes [10]. Since the known aminoglycoside-
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Figure 1. pH dependence of adenylylation reaction
with tobramycin adenylyltransferase. Reaction mix-
tures were prepared at the indicated pH values with
use of appropriate buffers. (0--0) = citrate-
phosphate buffer, pH 3.8-6.0; (e--e) = Tris-
maleate buffer, pH 5.5-7.5; (6--6) = barbital
buffer, pH 7.5-9.0; (. .) = glycine-NaOH
buffer, pH 9.0-10.0. Incubation at 35 C lasted for
2.5 min with tobramycin and for 9 min with paromo-
mycin. These periods of incubation were in the linear
range of assay at the indicated pH values.
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inactivating enzymes are periplasmic enzymes and
are released from R-factor-containing gram-
negative bacteria by osmotic shock [2], the same
procedure was used for extraction of the enzyme
from S. epidermidis strain 109.
Those drugs that are substrates for the enzyme
were inactivated when the reaction mixture con-
tained ATP. No inactivation was observed when
the reaction mixture contained either acetyl
coenzyme A or cell extracts from tobramycin-
susceptible variants. All of the drugs except
gentamicins C1a, C2, and C3, sisomycin, strepto-
mycin, and spectinomycin were inactivated (table
1) .
Adenylylation of aminoglycosides. Since ATP
was required for inactivation of the enzyme, we
assumed that the antibiotics were modified either
by O-adenylylation or O-phosphorylation. No
transfer of radioactivity from [y_32P]ATP to the
aminoglycosides was detectable in the enzymatic
assay. Radioactivity was, however, transferred to
the drugs from [2-3H]ATP. The optimal pH for
enzymatic reaction with tobramycin, kanamycin
A, B, and C, the butirosins, and gentamicin A
was 5.5; with amikacin it was 6.0, although
adenylylation occurred over. a broad range of pH
(4.5-9.5). Adenylylation of paromomycin, neo-
mycin B, and neomycin C had two pfl optima,
5.5 and 9.0 (figure 1).
The efficiencies of adenylylation of the different
aminoglycosides by tobramycin adenylytransferase
at pH 5.5 are listed in table 2. It can be seen
that this enzyme is different from both strepto-
mycin-spectinomycin adenylyltransferase and
gentamicin adenylyltransferase, since strepto-
mycin and spectinomycin, the gentamicins Cta, Ct,
and C2, and sisomicin are not adenylylated [10].
At pH 5.5, tobramycin is one of the best sub-
strates, whereas amikacin is a rather poor one. In
general, the efficiency data reflect the phenotypic
resistance of strain 109, except in the case of neo-
mycin B, which is readily adenylylated but weakly
inhibitory to the strain. Adenylylation therefore
may inactivate the drug incompletely, an effect
resulting in a low MIC value.
When the kinetics of adenylylation were
examined, it was found that some antibiotics were
Strain
109 (TmS )
Buffer* plus ATPt
Acetyl
CoAATP
Table 1. Effects of adenosine triphosphate (ATP)
and acetyl coenzyme A (acetyl CoA) on inactivation
of aminoglycoside antibiotics by lysates of osmotic-
ally shocked Staphylococcus epidermidis strain 109.
Strain 109 plus
Antibiotic
NOTE. Inactivation was determined by the agar diffu-
sion test as described in Materials and Methods. A plus
sign indicates that the antibiotics were inactivated; a
minus sign indicates no inactivation in comparison with
results in appropriate controls. Unlabeled ATP (20 nmol)
or unlabeled acetyl CoA (10 nmol) was used in each
assay.
* The buffer used was Tris-maleate (pH 5.5).
t Strain 109 (Tm S ) is a spontaneous, tobramycin-sus-
ceptible variant of strain 109.
Tobramycin +
NeomycinB +
Butirosin +
Kanamycin A +
Gentamicin A +
Paromomycin +
Amikacin +
Gentamicins
Cta' c, C2
Sisomicin
Streptomycin
Spectinomycin
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Gentamicin CIa 237 0 <0.047
Gentamicin C 2 168 0 <0.047
Gentamicin C I 223 0 <0.047
Sisomicin 172 0 <0.047
Streptomycin 203 0 >400
Spectinomycin 222 0 25
None 230 0
'" ATP =adenosine triphosphate. The assays were per-
formed as described in Materials and Methods. Samples
were incubated for 6 min with all substrates to ensure an
assay in the linear range. Efficiency of adenylylation was
calculated with reference to radioactivity of the adenyly-
lated tobramycin. A count of 2,950 cpm/min was equated
with 100% efficiency. Controls devoid of either enzyme
or drug had an average value of 230 cpm.
t MICs of drugs were determined in Mueller-Hinton
broth [8].
Table 2. Adenylylation of aminoglycoside
otics by celI-free extracts of Staphylococcus
midis strain 109.
[2-3H]ATP Percentage
incorporated of ATP
(cpm) '" incorporated
Discussion
T08RAMVC!N
In recent years it has become apparent that, under
some circumstances, S. epidermidis can be con-
sidered to be as pathogenic as Staphylococcus
aureus. Certain infections, such as endocarditis,
urinary tract infections, and colonization of
ventriculoatrial shunts are typically caused by
S. epidermidis [11-14]. In addition, this organism
can sometimes be isolated in pure culture from
pyogenic material. The isolated bacteria often
prove to be quite resistant to antibiotics [15-17].
Resistance to all ~-lactam antibiotics, to the
tetracyclines, to erythromycin, streptomycin, and
the sulfonamides, and often also to kanamycin,
neomycin, and chloramphenicol has been demon-
strated [18]. Thus the new aminoglycoside anti-
biotics may become significant aids in the treat-
ment of staphylococcal infections.
However, we have found that some S. epider-
midis strains are resistant to multiple drugs,
including many of the new aminoglycoside anti-
biotics. A previous genetic study revealed that
the determinants of resistance to aminoglycosides
in representative strains of these staphylococci
are plasmid-borne and can be transduced between
antibi-
epider-
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Figure 2. Kinetics of adenylylation of various
aminoglycoside antibiotics. Samples were incubated at
35 C for various periods, after which 50-~1 portions
were pipetted onto a phosphocellulose paper which
was washed and counted for radioactivity.
adenylylated at approximately the same rate but
not to the same extent (figure 2). A possible
explanation for this behavior is that the end
products differ slightly in ability to inhibit the
enzymatic reaction. However, such inhibition
does not seem to be a major factor in determin-
ing levels of resistance in intact bacteria (table 2).
Properties of tobramycin adenylyltransferase.
Of the three methods tested, osmotic shock yields
a preparation with the highest enzymatic activity.
Like other aminoglycoside-inactivating enzymes,
the enzyme has an absolute requirement for
Mg+ + ions. Dithiothreitol stabilizes the enzyme
significantly. The transferase is stable for at least
60 days when stored at -40 C in the presence of
dithiothreitol. Nearly 90% of activity was lost
after storage for 60 days at 4 C and for one week
at 22 C (table 3).
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Table 3. Properties of tobramycin adenylyltrans-
ferase.
Adenylylation
Property (% ) *
Preparation of enzymet
Osmotic lysate (0.5 mg of protein/ml) 100
Sonified extract (1.0 mg of protein/ml) 54
Lysed extract (2.9 mg of proteiri/rnl ) 11
Mg+ + requirement (per assay) t
No~ 4
0.05J,tmol 33
0.1 umol 64
0.3 umol 88
0.5 urnol 97
0.7 urnol 100
1.0 urnol 95
2.0 umol 91
Dithiothreitol requirement (per assay) §
None 44
55 nmol 100
Stability (days) t
o
1
6
7
20
30
60
* Adenylylation values listed in relation to the property
of stability were obtained at -40 C, 4 C, and 22 C, re-
spectively.
t Activity was measured after incubation for 30 min at
35 C, with neomycin B as substrate, in Tris-HCI buffer
(pH 8.0). A count of 3,658/min was equated with 100%
activity.
t Activity was measured after incubation for 15 min at
35 C, with tobramycin as substrate, in Tris-maleate buffer
(pH 5.5). A count of 5,276/min was equated with 100%
activity.
§ Activity was measured after incubation for 6 min at
35 C, with neomycin B as substrate, in Tris-rnaleate buffer
(pH 5.5). A count of 3,884/min was equated with 100%
activity.
strains with rather high frequency [1]. The size
and other characteristics of this extrachromo-
somal element are not unusual for staphylococci
[1]. However, the plasmid is unusual, insofar as
it carries the determinants for production of an
aminoglycoside-inactivating enzyme with a broad
range of activity. To our knowledge, an enzyme
with the properties of tobramycin adenylyltrans-
ferase has not been found in either gram-positive
or gram-negative bacteria.
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Although the end products of enzymatic re-
action are yet to be isolated and identified, the
substrate profile strongly suggests that adenylyla-
tion occurs at the 4' -hydroxyl group of ring I of
these antibiotics. The kanamycins, the neomycins,
the butirosins, paromomycin, amikacin, genta-
micin A, and tobramycin all contain such a group
in this position, whereas sisomicin and gentamicins
Ct a, Ct, and C2 do not (figure 3). Except for
butirosin, all of the substrates have yet another
hydroxyl group that can be adenylylated (i.e.,
the 4"-hydroxyl group of ring III of tobramycin,
gentamicin A, the kanamycins, and amikacin, and
the 4'"-hydroxyl group of ring IV of the neo-
mycins and paromomycin. Whether or not this
second hydroxyl group is also adenylylated re-
mains to be determined after analysis of the
adenylylated antibiotics.
The demonstration of a tobramycin adenylyl-
transferase that inactivates the classical amino-
glycosides as well as some of the newer antibiotics
of this group implies that no guarantees of free-
dom from resistance to antibiotics of the future
can be given. Thus, although resistance to
gentamicin has not been found in staphylococci
isolated in our area despite use of the drug for a
decade, it is perhaps only a matter of time before
resistant strains appear. If such resistance is
plasmid-borne, the widespread intraspecies and
perhaps also interspecies distribution [19] of this
plasmid under appropriate selective conditions in
vivo might result. Therefore, an important aspect
of antistaphylococcal chemotherapy in the future
should be a restriction of the use of the new,
highly potent antibiotics to cases in which these
drugs are absolutely necessary.
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